Catalyst Wire Dossier Catalyst Wire Dossier

PT001

· Pearl Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for PT001, covering 2013-06-21 to 2020-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma [Phase 2, Phase 3]

See pricing